Introduction: Why IBC now?

Naoto T. Ueno; Massimo Cristofanilli

doi:10.1007/978-94-007-3907-9_1

Introduction: Why IBC now?

Naoto T. Ueno, Massimo Cristofanilli

Breast Medical Oncology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

We are truly honored to provide the first textbook related to inflammatory breast cancer. This inflammatory breast cancer is rare but the most aggressive form of breast cancer. Despite it has a distinct clinical presentation, we have yet to establish the pathogenesis of this disease. The disease does not have molecularly defined diagnostic criteria and we are not able to establish the definitive inflammatory breast cancer specific treatment. Therefore, there is a strong need for a clinical and a scientific advancement of this disease.

Original language	English (US)
Title of host publication	Inflammatory Breast Cancer
Subtitle of host publication	An Update
Publisher	Springer Netherlands
Pages	1-2
Number of pages	2
ISBN (Electronic)	9789400739079
ISBN (Print)	9789400739062
DOIs	https://doi.org/10.1007/978-94-007-3907-9_1
State	Published - Jan 1 2012

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-94-007-3907-9_1

Cite this

@inbook{1392e396dcaa458eb7722b84fe69ef8f,

title = "Introduction: Why IBC now?",

abstract = "We are truly honored to provide the first textbook related to inflammatory breast cancer. This inflammatory breast cancer is rare but the most aggressive form of breast cancer. Despite it has a distinct clinical presentation, we have yet to establish the pathogenesis of this disease. The disease does not have molecularly defined diagnostic criteria and we are not able to establish the definitive inflammatory breast cancer specific treatment. Therefore, there is a strong need for a clinical and a scientific advancement of this disease.",

author = "Ueno, {Naoto T.} and Massimo Cristofanilli",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media B.V. 2012.",

year = "2012",

month = jan,

day = "1",

doi = "10.1007/978-94-007-3907-9_1",

language = "English (US)",

isbn = "9789400739062",

pages = "1--2",

booktitle = "Inflammatory Breast Cancer",

publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Introduction

T2 - Why IBC now?

AU - Ueno, Naoto T.

AU - Cristofanilli, Massimo

PY - 2012/1/1

Y1 - 2012/1/1

N2 - We are truly honored to provide the first textbook related to inflammatory breast cancer. This inflammatory breast cancer is rare but the most aggressive form of breast cancer. Despite it has a distinct clinical presentation, we have yet to establish the pathogenesis of this disease. The disease does not have molecularly defined diagnostic criteria and we are not able to establish the definitive inflammatory breast cancer specific treatment. Therefore, there is a strong need for a clinical and a scientific advancement of this disease.

AB - We are truly honored to provide the first textbook related to inflammatory breast cancer. This inflammatory breast cancer is rare but the most aggressive form of breast cancer. Despite it has a distinct clinical presentation, we have yet to establish the pathogenesis of this disease. The disease does not have molecularly defined diagnostic criteria and we are not able to establish the definitive inflammatory breast cancer specific treatment. Therefore, there is a strong need for a clinical and a scientific advancement of this disease.

UR - http://www.scopus.com/inward/record.url?scp=84956488710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956488710&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-3907-9_1

DO - 10.1007/978-94-007-3907-9_1

M3 - Chapter

AN - SCOPUS:84956488710

SN - 9789400739062

SP - 1

EP - 2

BT - Inflammatory Breast Cancer

PB - Springer Netherlands

ER -

Introduction: Why IBC now?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this